Australia
PHASE II STUDY OF PAXALISIB IN BRAIN METASTASES ADVANCES TO EXPANSION STAGE IN BREAST CANCER BRAIN METASTASES COHORT
SYDNEY, June 7, 2022 Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that a phase II, genomically-guided study of multiple therapies in patients with brain metastases, led by the Alliance for Clinical Trials in Oncology (NC...
2022-06-07 19:00
1796
Landis+Gyr's EV Charging Business Picks Up Speed with Software Contract in New Zealand
Meridian Energy will deploy the OCEAN Charge Point Management System for the management and monetization of their public charging network across the country. CHAM, Switzerland, June 7, 2022 /PRNewswire/ -- Etrel, a Landis+Gyr (SIX: LAND) company providing integrated e-mobility solutions, and Meri...
2022-06-07 16:00
1614
IND approval from the US FDA for Phase II SAR-Bombesin imaging trial in prostate cancer
Highlights * IND approval received for SAR-Bombesin product, enabling a Phase II "SABRE" imaging trial to detect prostate cancer in up to 50 PSMA-negative participants in the US * Approximately 20% of prostate cancer patients with biochemical recurrence (BCR) are PSMA-PET negative and theref...
2022-06-06 21:08
2234
Pepper Money's SOLANA Improves Business Volumes by 70% with the Appian Low-Code Platform
SYDNEY, June 6, 2022 /PRNewswire/ -- Appian (NASDAQ: APPN) announced today that Pepper Money, a leading consumer finance company inAustralia is using the Appian Low-Code Platform to support its Asset Finance Loan Origination solution, SOLANA, which has allowed the company to grow its business vol...
2022-06-06 07:00
3614
KAZIA PRESENTS POSITIVE FINAL DATA FROM PHASE II STUDY OF PAXALISIB IN NEWLY DIAGNOSED GLIOBLASTOMA AT ASCO CONFERENCE
SYDNEY, June 3, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce final data from its phase II study of paxalisib as first line therapy in patients with glioblastoma (NCT03522298). The data is the subj...
2022-06-03 19:00
8707
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial for the Treatment of Patients with Multiple System Atrophy
Multiple System Atrophy is a rare, rapidly progressive, neurodegenerative disease that causes profound disability MELBOURNE, Australia, June 2, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disea...
2022-06-02 20:00
2421
Avulux and CR Surfacing partner to make innovative migraine & light sensitivity lenses available through eye-care practitioners across Australia
Australians living with migraine can now come 'out of the dark' with Avulux migraine lenses DANDENONG SOUTH, Australia, June 1, 2022 /PRNewswire/ -- The world's first clinically proven lens for migraine and light sensitivity management is now available through eye-care practitioners inAustralia....
2022-06-01 05:00
2400
GBM AGILE OPENS TO PAXALISIB IN EUROPE
SYDNEY, May 31, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that the GBM AGILE study in glioblastoma (NCT03970447) has opened recruitment to the paxalisib arm inEurope. University Hospital Zurich...
2022-05-31 19:20
3250
KnowBe4 Makes Strategic Hire for Australia and New Zealand to Help Drive APAC Growth Efforts
Experienced sales leader Natalie "Nat" Burrows joins KnowBe4's executive team as director of sales forAustralia and New Zealand MELBOURNE, Australia, May 31, 2022 /PRNewswire/ -- KnowBe4, the provider of the world's largest security awareness training and simulated phishing platform, today annou...
2022-05-31 06:00
1857
Dr Neal Shore joins Clarity's Clinical Advisory Board
SYDNEY, May 26, 2022 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the growing needs in oncology, is pleased to announce that DrNeal Shore has joined Clarity's Clinical Advisory Board (C...
2022-05-26 21:08
2216
CONCEPT DESIGN MILESTONE FOR DHS SELF-SCREEN CHECKPOINT STATION ACHIEVED
Successful first stage design milestone for Micro-X Passenger Self screening station - Unlocks$0.7m second phase of work ADELAIDE, Australia and SEATTLE, May 24, 2022 /PRNewswire/ -- Australian hi-tech company Micro-X Ltd (ASX:MX1) (Micro-X or the Company), a leader in cold cathode x-ray technol...
2022-05-24 19:00
1750
KAZIA THERAPEUTICS TO PRESENT AT UPCOMING INVESTOR CONFERENCES HOSTED BY HC WAINWRIGHT AND LD MICRO
SYDNEY, May 23, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that CEO, DrJames Garner, will be presenting at two upcoming investor conferences. Dr Garner will present on behalf of Kazia at the HC ...
2022-05-23 20:30
3028
LiveHire wins HR Tech Award for "Best Innovative or Emerging Tech Solution"
MIAMI, May 20, 2022 /PRNewswire/ -- LiveHire Ltd. (ASX:LVH), a global
software-as-a-service (SaaS) platform connecting companies and candidates, wins
theHR Tech Award
2022-05-20 12:15
1980
HIF Global and Uniper Sign Letter of Intent to Produce, Sell eFuels
HIF Global expects to produce approximately 4 million tons per year of eFuels from four commercial plants in Magallanes,Chile HOUSTON and SYDNEY and SANTIAGO, Chile and DÜSSELDORF, Germany, May 20, 2022 /PRNewswire/ -- HIF Global, HIF Chile and Uniper Global Commodities (Uniper) signed a Letter ...
2022-05-20 07:00
2182
Accelerate your Contingent Talent Time-to-Hire with LiveHire and myBasePay
Bringing industry leading candidate experience to the contingent workforce MIAMI, Fla., May 19, 2022 /PRNewswire/ -- LiveHire Ltd. (ASX: LVH), a globally-leading Direct Sourcing platform, today announced a new partnership with myBasePay, a leading employer-of-record (EOR) and agent-of-record (AOR...
2022-05-20 00:33
2385
LiveHire and Viventis Announce Strategic Alliance to Deliver solutions for Total Talent Acquisition, Contingent Workforce and Direct Sourcing
SYDNEY and MANILA and MIAMI, May 17, 2022 /PRNewswire/ -- LiveHire (LVH:ASX) the global provider of Total Talent and Direct Sourcing Technology & SaaS platform and Viventis Search Asia, a leading executive search and human capital consulting firm inAsia-Pacific (APAC), formally announced a strat...
2022-05-18 01:34
2158
KAZIA MARKS DIPG AWARENESS DAY; NEW PRECLINICAL DATA IN DIPG TO BE PRESENTED AT ISPNO CONFERENCE
SYDNEY, May 17, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), a late-stage, oncology-focused drug development company, marks 'DIPG Awareness Day' by recognizing the tireless work of global researchers in this disease, and by calling for an increased focus on childhood ...
2022-05-17 20:00
1646
GeneQuantum Healthcare's Two Next Generation Bioconjugate Drugs, GQ1005 and GQ1007, Have Been Approved for Clinical Trials in Australia
SUZHOU, China, May 15, 2022 /PRNewswire/ -- GeneQuantum Healthcare (Suzhou) Co., Ltd. (hereinafter referred to as "GeneQuantum"), a global innovative biotechnology company dedicated to the development of bioconjugate drugs, announced that two of the company's bioconjugate drug candidates have won...
2022-05-16 09:00
2162
HR Tech Disruptor HiBob Partners with Deputy to Streamline Administration of Shift Employees
New product integration eliminates duplicative manual data entry for Bob customers that use Deputy to manage and schedule shift workers SYDNEY, May 13, 2022 /PRNewswire/ -- HR platform and people management disruptor HiBob has joined forces with Deputy, the workforce management app, to support ...
2022-05-13 07:00
2011
CRUNCHYROLL ANNOUNCES THE GLOBAL THEATRICAL RELEASE FOR "DRAGON BALL SUPER: SUPER HERO" THIS WINTER
Crunchyroll's First Worldwide Release Coming to Cinemas Starting August with Global Distribution by Crunchyroll and Sony Pictures Entertainment MELBOURNE, Australia, May 12, 2022 /PRNewswire/ -- Crunchyroll and Toei Animation today announced it will releaseDragon Ball Super: SUPER HERO, the newe...
2022-05-12 03:21
2629
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 312 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Oxygen, HubSpot's leading solutions partner in Hong Kong & Greater China Expands to UAE
[Picked up by 296 media titles]
2024-11-15 15:25
Most Read
Oxygen, HubSpot's leading solutions partner in Hong Kong & Greater China Expands to UAE
2024-11-15 15:25
8700
How "small apples" march into "big industry" in Yan'an
2024-11-15 17:39
5793
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5179
